Syros Pharmaceuticals Inc.. (SYRS) NASDAQ

$3.97 -0.16 (-3.87%)

Market Cap: $245.93M

As of 11/26/21 01:00 PM EST. Market closed.

(SYRS)

Syros Pharmaceuticals Inc.. (SYRS) NASDAQ

$3.97 -0.16 (-3.87%)

Market Cap: $245.93M

As of 11/26/21 01:00 PM EST. Market closed.

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust clinical-stage pipeline, including: SY-1425, a first-in-class oral ... read more

Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust clinical-stage pipeline, including: SY-1425, a first-in-class oral selective RAR? agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide in patients with acute promyelocytic leukemia; and SY-5609, a highly selective and potent oral CDK7 inhibitor in patients with select solid tumors. Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nancy Simonian
Full Time Employees
103
CEO Compensation (Base)
$560,000
CEO Compensation (Total)
$3.03M
URL
Address
35 Cambridge Park Drive, Massachusetts, Cambridge, 02140.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nancy Simonian
Full Time Employees
103
CEO Compensation (Base)
$560,000
CEO Compensation (Total)
$3.03M
URL
Address
35 Cambridge Park Drive, Massachusetts, Cambridge, 02140.
KEY STATS
Open
$3.98
Previous Close
$4.13
Days Range
$3.88 - $4.08
52 week range
$3.70 - $15.65
Volume
260,474
Avg. Volume (30 days)
385,817
Market Cap
$245.93M
Dividend Yield
0.00%
P/E
-2.65
Shares Outstanding
61,947,150
Open
$3.98
Previous Close
$4.13
Days Range
$3.88 - $4.08
52 week range
$3.70 - $15.65
Volume
260,474
Avg. Volume (30 days)
385,817
Market Cap
$245.93M
Dividend Yield
0.00%
P/E
-2.65
Shares Outstanding
61,947,150

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SYROS PHARMACEUTICALS INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Olson Eric R Chief Scientific Officer Jul 01, 2021 Sale $5.55 1,164 6,460 0 Jul 01, 2021, 05:20 PM
Olson Eric R Chief Scientific Officer Mar 15, 2021 Option Exercise $1.01 3,628 3,664 3,628 Mar 17, 2021, 05:10 PM
Olson Eric R Chief Scientific Officer Mar 15, 2021 Sale $9.47 3,628 34,372 0 Mar 17, 2021, 05:10 PM
Young Richard A Director Feb 16, 2021 Sale $12.05 3,750 45,188 321,711 Feb 18, 2021, 05:34 PM
Young Richard A Director Feb 08, 2021 Sale $13.04 3,750 48,900 325,461 Feb 10, 2021, 05:29 PM
Young Richard A Director Nov 17, 2020 Sale $8.75 5,357 46,874 329,211 Feb 10, 2021, 05:28 PM
Young Richard A Director Nov 16, 2020 Sale $8.98 633 5,684 334,568 Feb 10, 2021, 05:28 PM
Simonian Nancy A President & CEO Dec 18, 2020 Option Exercise $6.81 29,917 203,612 563,606 Dec 21, 2020, 04:58 PM
Young Richard A Director Nov 17, 2020 Sale $8.75 5,357 46,874 339,211 Nov 18, 2020, 04:33 PM
Young Richard A Director Nov 16, 2020 Sale $8.98 633 5,684 344,568 Nov 18, 2020, 04:33 PM
Young Richard A Director Oct 19, 2020 Sale $8.75 5,673 49,639 335,201 Oct 19, 2020, 06:36 PM
Young Richard A Director Oct 15, 2020 Sale $8.75 317 2,774 340,874 Oct 16, 2020, 04:39 PM
Young Richard A Director Sep 15, 2020 Sale $10.39 5,990 62,236 341,191 Sep 16, 2020, 08:32 AM
Olson Eric R Chief Scientific Officer Aug 17, 2020 Option Exercise $1.01 4,963 5,013 4,963 Aug 19, 2020, 04:35 PM
Olson Eric R Chief Scientific Officer Aug 18, 2020 Option Exercise $1.01 10,787 10,895 10,787 Aug 19, 2020, 04:35 PM
Olson Eric R Chief Scientific Officer Aug 18, 2020 Sale $13.00 10,787 140,231 0 Aug 19, 2020, 04:35 PM
Olson Eric R Chief Scientific Officer Aug 17, 2020 Sale $13.00 4,963 64,519 0 Aug 19, 2020, 04:35 PM
Young Richard A Director Aug 17, 2020 Sale $12.59 5,990 75,414 347,181 Aug 19, 2020, 04:33 PM
AKKARAJU SRINIVAS Director Aug 18, 2020 Sale $13.10 158,583 2,076,724 1,274,616 Aug 19, 2020, 04:03 PM
AKKARAJU SRINIVAS Director Aug 17, 2020 Sale $13.00 744 9,672 1,433,199 Aug 19, 2020, 04:03 PM
Young Richard A Director Jul 15, 2020 Sale $11.85 5,990 70,982 353,171 Jul 17, 2020, 04:11 PM
Olson Eric R Chief Scientific Officer Jul 07, 2020 Sale $11.72 1,753 20,538 0 Jul 07, 2020, 07:33 PM
AKKARAJU SRINIVAS Director Jul 01, 2020 Sale $11.01 4,627 50,966 1,433,943 Jul 06, 2020, 04:00 PM
AKKARAJU SRINIVAS Director Jun 24, 2020 Sale $11.07 48,775 539,788 1,493,542 Jun 25, 2020, 08:38 PM
AKKARAJU SRINIVAS Director Jun 23, 2020 Sale $11.11 50,953 565,930 1,542,317 Jun 25, 2020, 08:38 PM
AKKARAJU SRINIVAS Director Jun 25, 2020 Sale $11.15 54,972 612,850 1,438,570 Jun 25, 2020, 08:38 PM
Young Richard A Director Jun 15, 2020 Sale $8.75 5,990 52,413 359,161 Jun 16, 2020, 04:53 PM
Young Richard A Director May 15, 2020 Sale $9.22 5,990 55,242 365,151 May 15, 2020, 05:13 PM
Alles Mark J Director May 13, 2020 Buy $8.86 10,000 88,590 10,000 May 13, 2020, 05:05 PM
Young Richard A Director Apr 15, 2020 Sale $8.75 23,960 209,650 371,141 Apr 17, 2020, 04:02 PM
Olson Eric R Chief Scientific Officer Feb 18, 2020 Sale $7.38 1,446 10,674 0 Feb 20, 2020, 04:15 PM
Simonian Nancy A President & CEO Dec 23, 2019 Option Exercise $3.04 52,401 159,299 533,689 Dec 23, 2019, 04:54 PM
Springhorn Jeremy P. Chief Business Officer Nov 12, 2019 Buy $4.97 10,121 50,268 35,000 Nov 12, 2019, 04:34 PM
Springhorn Jeremy P. Chief Business Officer Nov 11, 2019 Buy $4.99 9,879 49,328 24,879 Nov 12, 2019, 04:34 PM
Young Richard A Director Aug 16, 2019 Sale $10.00 22,700 227,000 395,101 Aug 19, 2019, 04:08 PM
Young Richard A Director Aug 15, 2019 Sale $10.00 2,300 23,000 417,801 Aug 19, 2019, 04:08 PM
ARCH Venture Fund VII, L.P. 10% Owner Jul 17, 2019 Sale $7.70 34,521 265,687 4,242,051 Jul 17, 2019, 07:26 PM
ARCH Venture Fund VII, L.P. 10% Owner Jul 16, 2019 Sale $7.81 25,779 201,277 4,276,572 Jul 17, 2019, 07:26 PM
ARCH Venture Fund VII, L.P. 10% Owner Jul 15, 2019 Sale $8.27 2,700 22,316 4,302,051 Jul 17, 2019, 07:26 PM
AKKARAJU SRINIVAS Director Apr 09, 2019 Buy $7.50 533,332 3,999,990 1,593,270 Apr 11, 2019, 04:37 PM
ARCH Venture Fund VII, L.P. 10% Owner Mar 14, 2019 Sale $8.15 43,000 350,441 4,305,051 Mar 14, 2019, 06:57 PM
ARCH Venture Fund VII, L.P. 10% Owner Mar 13, 2019 Sale $7.90 84,411 666,565 4,350,871 Mar 14, 2019, 06:57 PM
ARCH Venture Fund VII, L.P. 10% Owner Mar 12, 2019 Sale $7.37 40,092 295,374 4,432,462 Mar 14, 2019, 06:57 PM
ARCH Venture Fund VII, L.P. 10% Owner Mar 08, 2019 Sale $6.93 84,496 585,270 4,517,432 Mar 11, 2019, 05:58 PM
ARCH Venture Fund VII, L.P. 10% Owner Mar 07, 2019 Sale $6.87 35,209 242,013 4,601,928 Mar 11, 2019, 05:58 PM
ARCH Venture Fund VII, L.P. 10% Owner Mar 11, 2019 Sale $6.49 44,878 291,366 4,472,554 Mar 11, 2019, 05:58 PM
Simonian Nancy A President & CEO Nov 29, 2018 Option Exercise $1.23 110,588 136,224 481,288 Dec 03, 2018, 04:06 PM
AKKARAJU SRINIVAS Director Jan 31, 2018 Buy $9.55 209,424 1,999,999 1,059,938 Feb 02, 2018, 03:53 PM
Springhorn Jeremy P. Chief Business Officer Dec 15, 2017 Buy $9.08 15,000 136,260 15,000 Dec 15, 2017, 04:02 PM
AKKARAJU SRINIVAS Director Dec 14, 2017 Buy $8.99 26,600 239,134 830,494 Dec 14, 2017, 08:22 PM
AKKARAJU SRINIVAS Director Dec 13, 2017 Buy $8.97 68,400 613,548 803,894 Dec 14, 2017, 08:22 PM
AKKARAJU SRINIVAS Director Dec 12, 2017 Buy $9.40 14,774 138,876 735,494 Dec 14, 2017, 08:22 PM
DeSimone Colleen Elizabeth Principal Accounting Officer Oct 23, 2017 Option Exercise $3.04 550 1,672 550 Oct 23, 2017, 04:44 PM
DeSimone Colleen Elizabeth Principal Accounting Officer Oct 23, 2017 Sale $16.06 550 8,833 0 Oct 23, 2017, 04:44 PM
Young Richard A Director Aug 14, 2017 Sale $22.00 3,282 72,204 420,101 Aug 16, 2017, 04:08 PM
Olson Eric R Chief Scientific Officer Aug 07, 2017 Option Exercise $1.01 2,500 2,525 2,500 Aug 08, 2017, 05:20 PM
Olson Eric R Chief Scientific Officer Aug 07, 2017 Sale $23.59 2,500 58,969 0 Aug 08, 2017, 05:20 PM
Olson Eric R Chief Scientific Officer Jul 25, 2017 Option Exercise $1.01 12,500 12,625 12,500 Jul 27, 2017, 04:09 PM
Olson Eric R Chief Scientific Officer Jul 25, 2017 Sale $21.85 12,500 273,125 0 Jul 27, 2017, 04:09 PM
Young Richard A Director Jul 25, 2017 Sale $22.09 3,282 72,496 423,383 Jul 27, 2017, 04:09 PM
Nashat Amir Director Jul 06, 2016 Buy $12.50 400,000 5,000,000 1,538,333 Jul 07, 2016, 05:41 PM
Polaris Management Co. VII, L.L.C. 10% Owner Jul 06, 2016 Buy $12.50 400,000 5,000,000 1,538,333 Jul 07, 2016, 05:41 PM
Flagship Ventures Fund IV, L.P. 10% Owner Jul 06, 2016 Buy $12.50 400,000 5,000,000 3,674,660 Jul 07, 2016, 06:04 AM
Redmile Group, LLC 10% Owner Jul 06, 2016 Buy $12.50 432,746 5,409,325 366,739 Jul 07, 2016, 06:03 AM
Arch Venture Fund VII LP 10% Owner Jul 06, 2016 Buy $12.50 400,000 5,000,000 4,637,137 Jul 07, 2016, 06:02 AM
NELSEN ROBERT Director Jul 06, 2016 Buy $12.50 400,000 5,000,000 4,637,137 Jul 06, 2016, 09:22 PM
AISLING CAPITAL III LP 10% Owner Jul 06, 2016 Buy $12.50 400,000 5,000,000 908,565 Jul 06, 2016, 05:10 PM
Flynn James E 10% Owner Jul 06, 2016 Buy $12.50 280,000 3,500,000 1,466,654 Jul 06, 2016, 11:54 AM
Flynn James E 10% Owner Jul 06, 2016 Buy $12.50 120,000 1,500,000 628,566 Jul 06, 2016, 11:54 AM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Olson Eric R Chief Scientific Officer 07/01/2021 6,460
Olson Eric R Chief Scientific Officer 03/15/2021 3,664
Olson Eric R Chief Scientific Officer 03/15/2021 34,372
Young Richard A Director 02/16/2021 45,188
Young Richard A Director 02/08/2021 48,900
Young Richard A Director 11/17/2020 46,874
Young Richard A Director 11/16/2020 5,684
Simonian Nancy A President & CEO 12/18/2020 203,612
Young Richard A Director 11/17/2020 46,874
Young Richard A Director 11/16/2020 5,684
Young Richard A Director 10/19/2020 49,639
Young Richard A Director 10/15/2020 2,774
Young Richard A Director 09/15/2020 62,236
Olson Eric R Chief Scientific Officer 08/17/2020 5,013
Olson Eric R Chief Scientific Officer 08/18/2020 10,895
Olson Eric R Chief Scientific Officer 08/18/2020 140,231
Olson Eric R Chief Scientific Officer 08/17/2020 64,519
Young Richard A Director 08/17/2020 75,414
AKKARAJU SRINIVAS Director 08/18/2020 2,076,724
AKKARAJU SRINIVAS Director 08/17/2020 9,672
Young Richard A Director 07/15/2020 70,982
Olson Eric R Chief Scientific Officer 07/07/2020 20,538
AKKARAJU SRINIVAS Director 07/01/2020 50,966
AKKARAJU SRINIVAS Director 06/24/2020 539,788
AKKARAJU SRINIVAS Director 06/23/2020 565,930
AKKARAJU SRINIVAS Director 06/25/2020 612,850
Young Richard A Director 06/15/2020 52,413
Young Richard A Director 05/15/2020 55,242
Alles Mark J Director 05/13/2020 88,590
Young Richard A Director 04/15/2020 209,650
Olson Eric R Chief Scientific Officer 02/18/2020 10,674
Simonian Nancy A President & CEO 12/23/2019 159,299
Springhorn Jeremy P. Chief Business Officer 11/12/2019 50,268
Springhorn Jeremy P. Chief Business Officer 11/11/2019 49,328
Young Richard A Director 08/16/2019 227,000
Young Richard A Director 08/15/2019 23,000
ARCH Venture Fund VII, L.P. 10% Owner 07/17/2019 265,687
ARCH Venture Fund VII, L.P. 10% Owner 07/16/2019 201,277
ARCH Venture Fund VII, L.P. 10% Owner 07/15/2019 22,316
AKKARAJU SRINIVAS Director 04/09/2019 3,999,990
ARCH Venture Fund VII, L.P. 10% Owner 03/14/2019 350,441
ARCH Venture Fund VII, L.P. 10% Owner 03/13/2019 666,565
ARCH Venture Fund VII, L.P. 10% Owner 03/12/2019 295,374
ARCH Venture Fund VII, L.P. 10% Owner 03/08/2019 585,270
ARCH Venture Fund VII, L.P. 10% Owner 03/07/2019 242,013
ARCH Venture Fund VII, L.P. 10% Owner 03/11/2019 291,366
Simonian Nancy A President & CEO 11/29/2018 136,224
AKKARAJU SRINIVAS Director 01/31/2018 1,999,999
Springhorn Jeremy P. Chief Business Officer 12/15/2017 136,260
AKKARAJU SRINIVAS Director 12/14/2017 239,134
AKKARAJU SRINIVAS Director 12/13/2017 613,548
AKKARAJU SRINIVAS Director 12/12/2017 138,876
DeSimone Colleen Elizabeth Principal Accounting Officer 10/23/2017 1,672
DeSimone Colleen Elizabeth Principal Accounting Officer 10/23/2017 8,833
Young Richard A Director 08/14/2017 72,204
Olson Eric R Chief Scientific Officer 08/07/2017 2,525
Olson Eric R Chief Scientific Officer 08/07/2017 58,969
Olson Eric R Chief Scientific Officer 07/25/2017 12,625
Olson Eric R Chief Scientific Officer 07/25/2017 273,125
Young Richard A Director 07/25/2017 72,496
Nashat Amir Director 07/06/2016 5,000,000
Polaris Management Co. VII, L.L.C. 10% Owner 07/06/2016 5,000,000
Flagship Ventures Fund IV, L.P. 10% Owner 07/06/2016 5,000,000
Redmile Group, LLC 10% Owner 07/06/2016 5,409,325
Arch Venture Fund VII LP 10% Owner 07/06/2016 5,000,000
NELSEN ROBERT Director 07/06/2016 5,000,000
AISLING CAPITAL III LP 10% Owner 07/06/2016 5,000,000
Flynn James E 10% Owner 07/06/2016 3,500,000
Flynn James E 10% Owner 07/06/2016 1,500,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.44%
1Q
09/30/2021
03/31/2021
1.65%
2Q
09/30/2021
12/31/2020
35.49%
3Q
09/30/2021
09/30/2020
38.23%
4Q
09/30/2021
06/30/2020
39.24%
5Q
09/30/2021
03/31/2020
42.05%
6Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.44%
1Q
03/31/2021
1.65%
2Q
12/31/2020
35.49%
3Q
09/30/2020
38.23%
4Q
06/30/2020
39.24%
5Q
03/31/2020
42.05%
6Q
Load More